Open Access · CC BY-NC 4.0
Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease
Journal of Neurology Research · 2026-09 · 16 (3) · 150-157
DOI: 10.14740/jnr1122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-09. Verfasst von Josh Landers und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Landers, J., Walker, C., & Skaddy, T. (2026). Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. Journal of Neurology Research, 16(3), 150-157. https://doi.org/10.14740/jnr1122
Vancouver
Landers J, Walker C, Skaddy T. Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. Journal of Neurology Research. 2026;16(3):150-157. doi:10.14740/jnr1122
BibTeX
@article{Landers2026,
author = {Landers, Josh and Walker, Cody and Skaddy, Tyler},
title = {Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease},
journal = {Journal of Neurology Research},
year = {2026},
volume = {16},
number = {3},
pages = {150--157},
doi = {10.14740/jnr1122}
}
EUVIMED